Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CALIFORNIA: Volunteers Sought for HIV Prevention Study




 

San Francisco Chronicle (09.25.12)

At a recent meeting of the San Francisco AIDS Foundation that took place at the San Francisco Department of Public Health, Oscar Bacon led a discussion about a new AIDS prevention pill. Bacon is the lead clinician for the San Francisco Clinic that is now seeking volunteers for the first demonstration trial of Truvada, produced by Gilead Sciences, Inc. Truvada is the first pill ever to block HIV before it strikes. Enrollment was opened on September 21 for 300 potential volunteers in the study. The study will examine how the drug will be received by people who are, so far, uninfected, but are at high risk. Recruiters are seeking study volunteers including transgender females and men who have sex with men (MSM). Participants will receive 48 weeks of the drug at no cost, in exchange for regular monitoring of their social habits and tests that will assess the pill’s effectiveness in preventing transmission of the virus.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in September 26, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.